(Q73740505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

placebo-controlled trial

1 reference

2

H J Möller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

H P Volz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

I Reimann

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

K D Stoll

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

European Neuropsychopharmacology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

211-217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

Blockade of hippocampal dopamine (DA) receptors: a tool for antipsychotics with low extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

Detection of dopamine receptors in homogenates of rat hippocampus and other brain areas.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

Somatization in the community: relationship to disability and use of services.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

Routine psychiatric examinations guided by ICD-10 diagnostic checklists (International Diagnostic Checklists).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

Opipramol in the climacteric syndrome. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

The Bradford Somatic Inventory. A multi-ethnic inventory of somatic symptoms reported by anxious and depressed patients in Britain and the Indo-Pakistan subcontinent

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

Observations on clinical aspects of hysteria; a quantitative study of 50 hysteria patients and 156 control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

Somatoform disorders--diagnostic concept, controlled clinical trials, and methodological issues

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

Does addition of low-dose flupentixol enhance the analgetic effects of low-dose amitriptyline in somatoform pain disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900074-2

7 January 2021

10.1016/S0924-977X(00)00074-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10793324%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference